MARSHALL WACE, LLP - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 83 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2019. The put-call ratio across all filers is 0.87 and the average weighting 1.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2021$67,000
-96.4%
15,572
-94.6%
0.00%
-100.0%
Q1 2019$1,866,000
+172.4%
289,954
+299.2%
0.01%
+28.6%
Q4 2018$685,00072,6380.01%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q2 2019
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 3,440,419$110,713,00017.54%
Consonance Capital Management LP 2,079,311$66,912,0006.04%
RTW INVESTMENTS, LP 1,063,170$34,213,0005.71%
Broadfin Capital, LLC 1,029,866$33,141,0005.42%
Perceptive Advisors 3,388,611$109,046,0003.62%
SECTORAL ASSET MANAGEMENT INC 854,301$27,491,0003.44%
Boxer Capital, LLC 267,500$8,608,0001.57%
Ghost Tree Capital, LLC 200,000$6,436,0001.51%
EMORY UNIVERSITY 51,632$1,662,0001.43%
Stanley-Laman Group, Ltd. 168,653$5,427,0001.17%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders